Literature DB >> 17922483

A possible link between the pubertal growth of girls and breast cancer in their daughters.

David J P Barker1, Clive Osmond, Kent L Thornburg, Eero Kajantie, Tom J Forsen, Johan G Eriksson.   

Abstract

One hypothesis for the origins of breast cancer is that it is initiated by exposure of developing breast tissue in utero to maternal sex hormones. The sex hormone profile is established at puberty, when it regulates growth of the pelvic bones. The pubertal growth of girls is characterized by broadening and rounding of the pelvis. The maximal width between their iliac crests, the intercristal width, increases more rapidly than in boys. We hypothesized that higher sex hormone concentrations at puberty produce larger intercristal widths, and these are markers of increased breast cancer risk in the next generation. We followed up 6,370 women who were born in Helsinki during 1934-1944, and whose mothers' pelvic bones were measured during routine antenatal care. Women whose mothers had large intercristal widths had higher rates of breast cancer. In those born at or after 40 weeks gestation, the hazard ratio for breast cancer was 3.7 (95% CI: 2.1-6.6) if their mother's intercristal width was greater than 30 cm. Among women born to multiparous mothers this hazard ratio rose to 7.2 (3.4-15.4). Hazard ratios for breast cancer were also higher in the daughters of mothers with round iliac crests. Pelvic bone measurements which increase similarly in girls and boys at puberty did not predict breast cancer. We conclude that the intercristal width, and the roundness of the iliac crests, are markers of mothers' sex hormones, and postulate that high concentrations cause genetic instability in differentiating breast cells in their daughters in utero.

Entities:  

Mesh:

Year:  2008        PMID: 17922483     DOI: 10.1002/ajhb.20688

Source DB:  PubMed          Journal:  Am J Hum Biol        ISSN: 1042-0533            Impact factor:   1.937


  8 in total

Review 1.  Role of nutrients in the development of neonatal immune response.

Authors:  Susanna Cunningham-Rundles; Hong Lin; Deborah Ho-Lin; Ann Dnistrian; Barrie R Cassileth; Jeffrey M Perlman
Journal:  Nutr Rev       Date:  2009-11       Impact factor: 7.110

Review 2.  The maternal womb: a novel target for cancer prevention in the era of the obesity pandemic?

Authors:  Frank A Simmen; Rosalia C M Simmen
Journal:  Eur J Cancer Prev       Date:  2011-11       Impact factor: 2.497

3.  In utero life and epigenetic predisposition for disease.

Authors:  Kent L Thornburg; Jackilen Shannon; Philippe Thuillier; Mitchell S Turker
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

Review 4.  Is early-onset cancer an emerging global epidemic? Current evidence and future implications.

Authors:  Tomotaka Ugai; Naoko Sasamoto; Hwa-Young Lee; Mariko Ando; Mingyang Song; Rulla M Tamimi; Ichiro Kawachi; Peter T Campbell; Edward L Giovannucci; Elisabete Weiderpass; Timothy R Rebbeck; Shuji Ogino
Journal:  Nat Rev Clin Oncol       Date:  2022-09-06       Impact factor: 65.011

5.  A possible link between the pubertal growth of girls and ovarian cancer in their daughters.

Authors:  David J P Barker; Clive Osmond; Kent L Thornburg; Eero Kajantie; Johan G Eriksson
Journal:  Am J Hum Biol       Date:  2008 Nov-Dec       Impact factor: 1.937

6.  A possible link between the pubertal growth of girls and prostate cancer in their sons.

Authors:  David J P Barker; Clive Osmond; Kent L Thornburg; Eero Kajantie; Johan G Eriksson
Journal:  Am J Hum Biol       Date:  2012-01-27       Impact factor: 1.937

7.  Diet, nutrition and modulation of genomic expression in fetal origins of adult disease.

Authors:  Alan A Jackson; Graham C Burdge; Karen A Lillicrop
Journal:  J Nutrigenet Nutrigenomics       Date:  2011-04-06

8.  A principal components approach to parent-to-newborn body composition associations in South India.

Authors:  Sargoor R Veena; Ghattu V Krishnaveni; Andrew K Wills; Jacqueline C Hill; Caroline Hd Fall
Journal:  BMC Pediatr       Date:  2009-02-24       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.